More prenatal visits linked to right level of care for infants born with heart defects

Published Date: 10 Nov 2025

In cases of mild congenital heart defects, more prenatal visits are associated with a greater likelihood of appropriate delivery at a community hospital, according to a study published in JAMA Network Open. Results suggest ...

Read Full News

Latest News

Lentigo Maligna Rarely Progresses Despite Rising Incidence

Despite rising cases in recent years, lentigo maligna shows minimal progression to melanoma, and patients with this condition are more likely to die due to other factors, a retrospective study finds.

Baxdrostat Approval May Open Doors for HTN Therapy

The FDA’s recent approval of baxdrostat may usher in new possibilities for treatment for uncontrolled hypertension.

Eating for One: The Future of Personalized Nutrition

Nutrition science is closing in on truly personalized dietary advice. The bigger challenge? Making sure it does not only land on wealthy plates.

When the Defibrillator Stays in Its Box

After teenage footballer Adam Ankers died in cardiac arrest while a defibrillator sat unused on the pitch, 13 organisations now have until June to respond to a coroner's report.

Is Hypertension Undertreated in Pediatrics?

Long-term implications may be underestimated, and new data show relatively low medication use.

Prior Auth Rules Vary Widely Across Insurers, Study Finds

A new study finds that prior authorization requirements vary widely across major insurers and suggests large language models could help streamline how authorization rules are interpreted and processed.

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Latest News

Despite rising cases in recent years, lentigo maligna shows minimal progression to melanoma, and patients with this condition are more likely to die due to other factors, a retrospective study finds.

The FDA’s recent approval of baxdrostat may usher in new possibilities for treatment for uncontrolled hypertension.

Nutrition science is closing in on truly personalized dietary advice. The bigger challenge? Making sure it does not only land on wealthy plates.

After teenage footballer Adam Ankers died in cardiac arrest while a defibrillator sat unused on the pitch, 13 organisations now have until June to respond to a coroner's report.

Long-term implications may be underestimated, and new data show relatively low medication use.

A new study finds that prior authorization requirements vary widely across major insurers and suggests large language models could help streamline how authorization rules are interpreted and processed.

News All Time

How Lifeline Brought the AMR Crisis to the London Stage

Real doctors joined the London cast of Lifeline the Musical to bring the growing threat of antimicrobial resistance to wider audiences.

Cardiorenal Benefits of GLP-1s Found in Type 1 Diabetes

A large database study shows lower risk for major adverse cardiovascular events and end-stage kidney disease, with no increase in adverse events.

Germany Flags Safety Risks in ‘Vitamin Drip’ Trend

BfArM warns ‘vitamin drips’ can cause hypervitaminosis, electrolyte imbalance, allergic reactions up to anaphylaxis, fluid overload, and IV complications such as air embolism.

Arterial Widening, Not Blockage, Tied to Common Stroke

Arterial widening, not vessel blockage, is strongly associated with lacunar stroke, a finding that could explain why conventional antiplatelet therapies offer limited benefit.

Single-Pill Hypertension Therapy Remains Underutilized

Single-pill combination therapy remains underused as the initial treatment for adults newly diagnosed with hypertension, despite repeated guideline recommendations.

Maternal Diabetes in Pregnancy Tied to CVD Risk in Children

Maternal diabetes during pregnancy is associated with an increased risk for cardiovascular disease in offspring, and part of this association is explained by birth complications.

Polycystic Ovary Syndrome Demands Multidisciplinary Approach

Along with endocrinologists, ob/gyns, mental health professionals, and nutritionists, dermatologists play a key role in addressing polycystic ovary syndrome, experts say.

Time in Target Range Metric May Aid in CKD Management

The urine albumin/creatinine ratio time in target range predicts cardiovascular outcomes in people with and without chronic kidney disease.

SSRI vs NDRI: Which Is Better for Post-Stroke Depression?

Bupropion is linked to lower suicidal ideation risk but higher odds of demoralization and apathy vs fluoxetine in post-stroke depression, new research shows.

TADV Saves Limbs in No-Option CLTI Patients

More than 80% of no-option chronic limb-threatening ischemia patients avoided amputation for 6 months after the procedure while enjoying improved wound healing and reduced pain.

Underground Hospitals: Is Combat Medicine Entering a New Era?

Ukrainian clinicians increasingly rely on protected underground facilities as drone threats complicate evacuation and strain traditional battlefield treatment models.

France Focuses on Drugs That Raise Fall Risk in Older Adults

Long-term benzodiazepines and anticholinergics drive falls in seniors; prioritize nonpharmacologic care and deprescribing to cut injuries and hospitalizations.

GLP-1 Drugs Tied to Cardiovascular Benefits in T1D

Adults with T1D who receive GLP-1-based therapy may have a lower risk for adverse cardiovascular outcomes and no significant increase in diabetic ketoacidosis compared with those who do not.

Uraemic Marker Predicts Mortality After Kidney Transplant

Plasma levels of symmetric dimethylarginine are independently associated with an increased risk for mortality in adult kidney transplant recipients, a prospective study finds.

Transient Neurologic Symptoms: What Clinicians Miss

Speakers warn that transient neurologic events may conceal high-risk vascular disease, seizures, or amnestic syndromes requiring rapid evaluation.

SGLT2 Inhibitors Show Similar Cardiorenal Benefits

Empagliflozin and dapagliflozin show similar effectiveness in preventing cardiorenal outcomes among patients with type 2 diabetes without prior cardiovascular or renal disease.

Recommended News For You

Let's Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging?

Legal, Recreational Marijuana Linked to Higher CUD Prevalence.

Indoor hydroponic gardening can improve mental health and quality of life for cancer patients

Radiation from CT scans could account for 5% of all cancer cases a year, study suggests

MCh in Gynecologic Oncology: Admission, Medical School, Fees, Qualifications Information

Study finds 20 minutes of mindful breathing can rapidly reduce intensity of cancer pain

Teenagers Frequently Use Delta-8 THC; New Drug-Coated Balloon Treats Blocked Stents.

Recommended Articles For You

The Significance of APTT Blood Test Results for Detecting Coagulation Disorders 

Insights into Doxorubicin and Liposomal Doxorubicin in Extra-Abdominal Desmoid-Type Fibromatosis 

The Pros and Cons of Using Cyclophosphamide in Cancer Treatment  

Neoadjuvant Abraxane Chemotherapy Combined with Neutrophil Cytopharmaceuticals and Radiotherapy 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Charles III, King of Kings, is Cancerous.

2.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

3.

Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival

4.

Merck enhances its oncology pipeline by means of a strategic alliance with Hengrui.

5.

WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research

1.

The benefits and risks of taking fludrocortisone for adrenal insufficiency 

2.

Ultimate Guide to Oncology Services in the USA

3.

Unveiling New Hope: Potential Therapeutic Targets in Hematological Malignancies

4.

Real-World Oncology Insights: CAR-T, Immunotherapy, PROs, and Digital Tools

5.

Introducing the Corrected Calcium Calculator: A Revolutionary Tool in Medical Assessment 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Oropharyngeal Cancer in Relation to HPV Status

2.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary

3.

Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC

4.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion

5.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot